These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12946271)

  • 21. Evolution of catalytic antibody repertoire in autoimmune mice.
    Nishi Y
    J Immunol Methods; 2002 Nov; 269(1-2):213-33. PubMed ID: 12379363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms of improvement of hydrolytic antibody 6D9 by site-directed mutagenesis.
    Takahashi-Ando N; Shimazaki K; Kakinuma H; Fujii I; Nishi Y
    J Biochem; 2006 Oct; 140(4):509-15. PubMed ID: 16921165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of a catalytic antibody with a serine protease active site.
    Zhou GW; Guo J; Huang W; Fletterick RJ; Scanlan TS
    Science; 1994 Aug; 265(5175):1059-64. PubMed ID: 8066444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remarkable remote chiral recognition in a reaction mediated by a catalytic antibody.
    D'Souza LJ; Gigant B; Knossow M; Green BS
    J Am Chem Soc; 2002 Mar; 124(10):2114-5. PubMed ID: 11878955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catalytic mechanism of hamster arylamine N-acetyltransferase 2.
    Wang H; Liu L; Hanna PE; Wagner CR
    Biochemistry; 2005 Aug; 44(33):11295-306. PubMed ID: 16101314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody catalysis via strategic use of haptenic charge.
    Kikuchi K; Hilvert D
    Acta Chem Scand (Cph); 1996 Apr; 50(4):333-6. PubMed ID: 8639376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for a catalytic dyad in the active site of homocitrate synthase from Saccharomyces cerevisiae.
    Qian J; Khandogin J; West AH; Cook PF
    Biochemistry; 2008 Jul; 47(26):6851-8. PubMed ID: 18533686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Squaric monoamide monoester as a new class of reactive immunization hapten for catalytic antibodies.
    Xu Y; Yamamoto N; Ruiz DI; Kubitz DS; Janda KD
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4304-7. PubMed ID: 16046128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hapten design for the generation of catalytic antibodies.
    Thomas NR
    Appl Biochem Biotechnol; 1994; 47(2-3):345-72. PubMed ID: 7944348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positional ordering of reacting groups contributes significantly to the efficiency of proton transfer at an antibody active site.
    Seebeck FP; Hilvert D
    J Am Chem Soc; 2005 Feb; 127(4):1307-12. PubMed ID: 15669871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of the enzymic mechanism of Candida tenuis xylose reductase (AKR 2B5): X-ray structure and catalytic reaction profile for the H113A mutant.
    Kratzer R; Kavanagh KL; Wilson DK; Nidetzky B
    Biochemistry; 2004 May; 43(17):4944-54. PubMed ID: 15109252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that the mechanism of antibody-catalysed hydrolysis of arylcarbamates can be determined by the structure of the immunogen used to elicit the catalytic antibody.
    Boucher G; Said B; Ostler EL; Resmini M; Brocklehurst K; Gallacher G
    Biochem J; 2007 Feb; 401(3):721-6. PubMed ID: 17020536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrolytic cleavage of an RNA-model phosphodiester catalyzed by a highly negatively charged polyoxomolybdate [Mo7O24]6- cluster.
    Absillis G; Cartuyvels E; Van Deun R; Parac-Vogt TN
    J Am Chem Soc; 2008 Dec; 130(51):17400-8. PubMed ID: 19053457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton inventory studies of alpha-thrombin-catalyzed reactions of substrates with selected P and P' sites.
    Enyedy EJ; Kovach IM
    J Am Chem Soc; 2004 May; 126(19):6017-24. PubMed ID: 15137766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A bait and switch hapten strategy generates catalytic antibodies for phosphodiester hydrolysis.
    Wentworth P; Liu Y; Wentworth AD; Fan P; Foley MJ; Janda KD
    Proc Natl Acad Sci U S A; 1998 May; 95(11):5971-5. PubMed ID: 9600901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cocaine catalytic antibodies: the primary importance of linker effects.
    Matsushita M; Hoffman TZ; Ashley JA; Zhou B; Wirsching P; Janda KD
    Bioorg Med Chem Lett; 2001 Jan; 11(2):87-90. PubMed ID: 11206477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of phosphonate analogues of the tetrahedral reaction intermediate with 5-enolpyruvylshikimate-3-phosphate synthase in atomic detail.
    Priestman MA; Healy ML; Becker A; Alberg DG; Bartlett PA; Lushington GH; Schönbrunn E
    Biochemistry; 2005 Mar; 44(9):3241-8. PubMed ID: 15736934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metalloantibodies: mercury(II)-dependent acyl transferases.
    Brümmer O; Hoffman TZ; Janda KD
    Bioorg Med Chem; 2001 Sep; 9(9):2253-7. PubMed ID: 11553463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple reactive immunization towards the hydrolysis of organophosphorus nerve agents: hapten design and synthesis.
    Huang H; Han WG; Noodleman L; Grynszpan F
    Bioorg Med Chem; 2001 Dec; 9(12):3185-95. PubMed ID: 11711294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the question of stepwise vs. concerted cleavage of RNA models promoted by a synthetic dinuclear Zn(II) complex in methanol: implementation of a noncleavable phosphonate probe.
    Edwards DR; Tsang WY; Neverov AA; Brown RS
    Org Biomol Chem; 2010 Feb; 8(4):822-7. PubMed ID: 20135039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.